HETEROAROMATIC MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA

The present invention relates to a compound according to general formula (I) wherein X represents N or CH; R1 is -CN, (C1-C6)alkyl, (C3-C7)cycloalkyl, (3-7 membered)heterocycloalkyl, (5-6 membered)heteroaryl, (C3-C7)cycloalkyl(C1-C4)alkyl, (3-7 membered)heterocycloalkyl-(C1-C4)alkyl or (5-6 membered...

Full description

Saved in:
Bibliographic Details
Main Authors JOHNSON, Patrick Stephen, MAANSSON, Kristoffer, JESSIMAN, Alan Stuart, SØRENSEN, Morten Dahl
Format Patent
LanguageEnglish
French
Published 18.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a compound according to general formula (I) wherein X represents N or CH; R1 is -CN, (C1-C6)alkyl, (C3-C7)cycloalkyl, (3-7 membered)heterocycloalkyl, (5-6 membered)heteroaryl, (C3-C7)cycloalkyl(C1-C4)alkyl, (3-7 membered)heterocycloalkyl-(C1-C4)alkyl or (5-6 membered)heteroaryl- (C1-C4)alkyl; R2 is halogen, cyano, (C1-C4)alkyl or (C3-C7)cycloalkyl; R3 is halogen, cyano, (C1-C4)alkyl, (C1-C4)haloalkyl or (C3-C7)cycloalkyl; R4 is (C1-C4)alkyl or (C1-C4)haloalkyl; R5 is (C1-C6)alkyl, (C3-C7)cycloalkyl, (C1-C6)alkyl-(C3-C7)cycloalkyl, (C3-C7)cycloalkyl-(C1-C6)alkyl, (3-7 membered)heterocycloalkyl, phenyl, (5-6 membered)heteroaryl or -ORa. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds and to intermediates for preparation of said compounds. La présente invention concerne des composés selon la formule générale (I) où X représente N ou CH; R1 est -CN, (C1-C6alkyle, (C3-C7 cycloalkyle, (3-7 membre)hétérocycloalkyle, (5-6 membre)hétéroaryle, (C3-C7) cycloalkyle (C1-C4 alkyle, (3-7 membre) hétérocycloalkyle-(C1-C4 alkyle ou (5-6 membre) hétéroaryle-(C1-C4 alkyle; R2 est un halogène, un cyano, (C1-C4 alkyle ou (C3-C7 cycloalkyle; R3 est un halogène, un cyano, (C1-C4 alkyle, (C1-C4 haloalkyle ou (C3-C7) cycloalkyle; R4 est (C1-C4 alkyle ou (C1-C4 haloalkyle; R5 est (C1-C6 alkyle, (C3-C7 cycloalkyle, (C1-C6 alkyle-(C3-C7) cycloalkyle, (C3-C7 cycloalkyle-(C1-C6) alkyle, (3-7 membre) hétérocycloalkyle, phényle, (5-6 membre) hétéroaryle ou ORa. L'invention concerne également lesdits composés pour l'utilisation en thérapie, des compositions pharmaceutiques comprenant ces composés et des produits intermédiaires pour la préparation desdits composés.
Bibliography:Application Number: WO2017EP67390